India’s specialty chemical substances sector is experiencing speedy progress, with a market dimension projected to achieve $64 billion by 2025, pushed by a CAGR of 12 p.c. The trade has grown considerably from $27 billion in 2018, pushed by home demand and exports, positioning India as a key world participant.
Worth Motion
With a market capitalization of Rs 8,573.00 crore, the shares of Anupam Rasayan India Ltd closed at Rs 779.85 per share, decreased round 0.33 p.c as in comparison with the earlier closing value of Rs 782.45 apiece.
Matter Rationalization
Anupam Rasayan India Ltd expects a 30-35 p.c income progress in FY ’26, pushed by sturdy demand in Pharma and Polymer segments. Development will likely be fueled by new product commercialization and a sturdy Rs 10,700 crore order e book, making certain sustained efficiency within the coming years.
Monetary efficiency
In Q3 FY ’25, consolidated income rose 32 p.c YoY to Rs 390 crores, EBITDA grew 48 p.c to Rs 121 crores (31 p.c margin, up 389 bps), and PAT surged 108 p.c to Rs 54 crores. Nonetheless, for the 9 months ending Dec 31, 2024, income fell 13 p.c YoY to Rs 938 crores, with EBITDA down 14 p.c to Rs 262 crores.
Development Drivers
Anupam’s progress is pushed by 17+ molecule launches in FY24 and 6+ deliberate for FY25, with 65+ in R&D. The Tanfac acquisition strengthens its fluorination chemistry with a secure KF and HF provide. Japan, backed by long-term contracts, is about to contribute one-third of gross sales in 2-3 years.
Capex and Sustainability Initiatives
The corporate has accomplished Rs 650 crores of its Rs 670 crores capex, with all crops set for commercialization by March 31, 2025. A Rs 59 crores funding in a 9.2 MW hybrid energy plant will save Rs 15 crores yearly. It targets 65 p.c of its electrical energy from inexperienced vitality.
Additionally learn: Mukul Agrawal inventory jumps after receiving $606,000 brass billets order from Dubai-based Co.
Margin Steering
The corporate expects EBITDA margins to remain secure between 26% and 28%, with a possible upward pattern pushed by enhancements within the product combine. This stability displays a robust operational outlook, making certain profitability stays constant whereas leveraging higher product positioning for incremental beneficial properties.
Working Capital and Debt Administration
As of December 31, 2024, the corporate’s whole debt stands at roughly ₹1,200 crores, decreased by way of time period mortgage repayments. It plans to decrease working capital days to 180-200 over
the subsequent 18 months, anticipating improved money stream as gross sales develop. This strategic focus goals to boost monetary stability and operational effectivity.
Firm Profile
Anupam Rasayan India Restricted is engaged within the customized synthesis and manufacturing of specialty chemical substances in India. The Firm’s segments embody Life Science Associated Specialty Chemical compounds and Different Specialty Chemical compounds.
Written by Abhishek Singh
Disclaimer
The views and funding suggestions expressed by funding consultants/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Buyers should subsequently train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the creator will not be chargeable for any losses brought on on account of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
